Large-scale testing (Phase 3)Study completedNCT01779258What this trial is testingEmollients in the Management of Atopic DermatitisWho this might be right forAtopic Dermatitis Pierre Fabre Medicament 347
Post-approval studies (Phase 4)UnknownNCT05578482What this trial is testingStaphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic DermatitisWho this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Dermatitis Flare Jacob Pontoppidan Thyssen 45
Not applicableStudy completedNCT02615561What this trial is testingCuring Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductWho this might be right forDermatitis, Atopic Bayer 136
Not applicableNot Yet RecruitingNCT07014007What this trial is testingTolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksWho this might be right forAtopic Dermatitis Pierre Fabre Dermo Cosmetique 105
Post-approval studies (Phase 4)WithdrawnNCT03710044What this trial is testingInvestigation of Flare and Remission in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis LEO Pharma
Large-scale testing (Phase 3)Study completedNCT04040192What this trial is testingEvaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Pfizer 620